GRIN2B and Stroke: Gene mutations targeting GluN2B subunits and specific antagonists (ifenprodil, Ro25-6981) can inhibit extra-synaptic rather than synaptic NMDAR activity, showing improvement of behavioral function and recovery of dendritic injury after stroke injury [132,133,134,135,136].